Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 18/20 | 0.73 |
| ▸ | MTNR1B | P49286 | 18/20 | 0.73 |
| ▸ | ACACB | O00763 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6579816 | 1.00 | MTNR1A (0.73) | MTNR1AMTNR1BACACBDRD2HTR2A | |
| SCHEMBL6582109 | 0.88 | MTNR1A (0.74) | MTNR1AMTNR1BACACB | |
| SCHEMBL6582110 | 0.88 | MTNR1A (0.74) | MTNR1AMTNR1BACACB | |
| SCHEMBL6582697 | 0.87 | MTNR1A (0.75) | MTNR1AMTNR1BDRD2HTR2ADRD3 | |
| SCHEMBL6583078 | 0.87 | MTNR1A (0.75) | MTNR1AMTNR1BDRD2HTR2ADRD3 | |
| SCHEMBL6583016 | 0.87 | MTNR1A (0.74) | MTNR1AMTNR1BDRD2HTR2ADRD3 | |
| SCHEMBL6583011 | 0.87 | MTNR1A (0.74) | MTNR1AMTNR1BDRD2HTR2ADRD3 | |
| SCHEMBL6582755 | 0.85 | MTNR1A (0.76) | MTNR1AMTNR1BDRD2HTR2ADRD3 | |
| SCHEMBL6581639 | 0.85 | MTNR1A (0.76) | MTNR1AMTNR1B | |
| SCHEMBL6582764 | 0.85 | MTNR1A (0.76) | MTNR1AMTNR1BDRD2HTR2ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189900-B1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2004-01-14 | — | — | EP | claimed |
| EP-1189900-A4 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2002-07-31 | — | — | EP | claimed |
| EP-1189900-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-27 | — | — | EP | claimed |
| US-6211225-B1 | SLEEP DISORDERS AND CIRCADIAN RHYTHM DISORDERS | BRISTOL-MEYERS SQUIBB | 2001-04-03 | — | — | US | claimed |
| WO-2001002392-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-01-11 | — | — | WO | claimed |
| EP-1189900-B1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2004-01-14 | — | — | EP | disclosed |
| EP-1189900-A4 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2002-07-31 | — | — | EP | disclosed |
| EP-1189900-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-27 | — | — | EP | disclosed |
| US-6211225-B1 | SLEEP DISORDERS AND CIRCADIAN RHYTHM DISORDERS | BRISTOL-MEYERS SQUIBB | 2001-04-03 | — | — | US | disclosed |
| WO-2001002392-A1 | HETEROCYCLIC AMINOPYRROLIDINE DERIVATIVES AS MELATONERGIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |